What is it about?

We report a 36-year-old white male, born and living in Brazil, without comorbidities presented to hematologist thrombotic episodes even under anticoagulant therapy. On his first hematologic appointment, he had no active complaints except by the fullness after meals, and his physical examination presented remarkable collateral circulation in the chest.In his magnetic resonance angiography of the thorax, a great amount of collateral circulation and communication of the azygos and hemiazygos veins with inferior vena cava were evident, as well as the absence of the upper cava vein. Furthermore, heterozygous genetic mutation was found for Leiden factor V.

Featured Image

Why is it important?

This case gives us the lesson that we need to include ASVC in the differential diagnosis of SVCS. The importance of the V-Leiden factor as a joint risk with this congenital defect for venous thromboembolism episodes was also highlighted.

Perspectives

The report of this case reinforces the need to include ASVC in the differential diagnosis of SVCS. The importance of the V-Leiden factor as a joint risk with this congenital defect for venous thromboembolism episodes was also confirmed. However, this association has an unknown impact on the ​medical practice until now.

Dr. VALTER ROMÃO DE SOUZA JUNIOR
University of Glasgow

Read the Original

This page is a summary of: The first reported case of factor V Leiden mutation with agenesis of superior vena cava, Medicine, June 2018, Wolters Kluwer Health,
DOI: 10.1097/md.0000000000010511.
You can read the full text:

Read

Contributors

The following have contributed to this page